Replies to post #747906 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

As of February 3, 2025, the MHRA recognizes DCVax-l could potentially have an impact on GBM. What’s your point?

February 3, 2025 (three days ago) MHRA said:

As you have already seen, the company has announced that they have submitted their application to us. We are working actively on this application, recognising the impact this medicine could potentially have.

Finally, please be assured we a[re] progressing this application as rapidly as possible and in collaboration with the company.”